Vinayak Venkataraman, Lily Weber, Lauren Fisher, Andrew Khalaj, Eirian Siegal-Botti, Diane Diehl, Katherine A Janeway, Suzanne George, Jennifer W Mack
{"title":"Supporting Participant Engagement in Cancer Genomics Research in Rare Cancers: A Qualitative Study of Patients, Caregivers, and Advocates.","authors":"Vinayak Venkataraman, Lily Weber, Lauren Fisher, Andrew Khalaj, Eirian Siegal-Botti, Diane Diehl, Katherine A Janeway, Suzanne George, Jennifer W Mack","doi":"10.1177/10732748251364041","DOIUrl":null,"url":null,"abstract":"<p><p>IntroductionThe purpose of this study was to identify patterns and themes that support participant engagement in patient-partnered cancer genomics research.MethodsThe Osteosarcoma (OS) and Leiomyosarcoma (LMS) Projects of Count Me In allow any patient with OS and LMS in the US and Canada to contribute their health information, tumor samples, and lived experience to an aggregated, public research database. We conducted in-depth interviews with research partners, including patients, caregivers, and advocates, who were purposefully sampled to ensure inclusion of racial and ethnic minorities, those with less than college education, and adolescents (age 12-17). Coding and analysis were conducted by the research team using NVivo to identify themes that support engagement.ResultsTen patients, ten caregivers, and six advocates were interviewed. Seven themes were identified that support participant engagement: (a) motivation, (b) respect, (c) trust, (d) inclusivity, (e) relationship, (f) engagement, and (g) empowerment. Research partners were motivated to serve others, play a part in scientific discovery, and play a role in a novel initiative. Respect was supported through timeliness in communication or follow-up, an appropriate amount of time and information requested, and an acknowledgement that illness may prevent participation. Trust was developed through ensuring adequate privacy/confidentiality safeguards and demonstrating transparency. Inclusivity was demonstrated through showcasing broad representation and mitigating technical barriers. Research partners wanted to feel a relationship with, and engaged and empowered by, researchers. Adolescents reported their parents were more engaged than they were.ConclusionsResearch partners, including patients, caregivers, and advocates, have a strong desire to engage with researchers. We identified seven themes to support engagement. Researchers can optimize their communication and operations to support participant engagement in cancer genomics research.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":"32 ","pages":"10732748251364041"},"PeriodicalIF":2.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304653/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10732748251364041","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
IntroductionThe purpose of this study was to identify patterns and themes that support participant engagement in patient-partnered cancer genomics research.MethodsThe Osteosarcoma (OS) and Leiomyosarcoma (LMS) Projects of Count Me In allow any patient with OS and LMS in the US and Canada to contribute their health information, tumor samples, and lived experience to an aggregated, public research database. We conducted in-depth interviews with research partners, including patients, caregivers, and advocates, who were purposefully sampled to ensure inclusion of racial and ethnic minorities, those with less than college education, and adolescents (age 12-17). Coding and analysis were conducted by the research team using NVivo to identify themes that support engagement.ResultsTen patients, ten caregivers, and six advocates were interviewed. Seven themes were identified that support participant engagement: (a) motivation, (b) respect, (c) trust, (d) inclusivity, (e) relationship, (f) engagement, and (g) empowerment. Research partners were motivated to serve others, play a part in scientific discovery, and play a role in a novel initiative. Respect was supported through timeliness in communication or follow-up, an appropriate amount of time and information requested, and an acknowledgement that illness may prevent participation. Trust was developed through ensuring adequate privacy/confidentiality safeguards and demonstrating transparency. Inclusivity was demonstrated through showcasing broad representation and mitigating technical barriers. Research partners wanted to feel a relationship with, and engaged and empowered by, researchers. Adolescents reported their parents were more engaged than they were.ConclusionsResearch partners, including patients, caregivers, and advocates, have a strong desire to engage with researchers. We identified seven themes to support engagement. Researchers can optimize their communication and operations to support participant engagement in cancer genomics research.
本研究的目的是确定支持参与者参与患者合作癌症基因组学研究的模式和主题。方法Count Me In的骨肉瘤(OS)和平滑肌肉瘤(LMS)项目允许美国和加拿大的任何骨肉瘤和平滑肌肉瘤患者将他们的健康信息、肿瘤样本和生活经验提供给一个汇总的公共研究数据库。我们对研究合作伙伴进行了深入访谈,包括患者、护理人员和倡导者,有目的地对他们进行抽样,以确保包括种族和少数民族、未受过大学教育的人和青少年(12-17岁)。研究团队使用NVivo进行编码和分析,以确定支持用户粘性的主题。结果对10名患者、10名护理人员和6名辩护人进行了访谈。确定了支持参与者参与的七个主题:(a)动机,(b)尊重,(c)信任,(d)包容性,(e)关系,(f)参与和(g)授权。研究伙伴被激励为他人服务,在科学发现中发挥作用,并在一个新的倡议中发挥作用。及时沟通或后续行动,要求适当的时间和信息,并承认疾病可能妨碍参与,从而支持尊重。通过确保充分的隐私/保密保障和展示透明度,建立了信任。通过展示广泛的代表性和减轻技术障碍,展示了包容性。研究伙伴希望感受到与研究人员的关系,并参与其中,并获得研究人员的授权。青少年报告说,他们的父母比他们更投入。研究合作伙伴,包括患者、护理人员和倡导者,都强烈希望与研究人员接触。我们确定了支持参与的七个主题。研究人员可以优化他们的沟通和操作,以支持参与者参与癌症基因组学研究。
期刊介绍:
Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.